4.5 Article

How to deal with vaccine hesitancy?

期刊

VACCINE
卷 33, 期 34, 页码 4215-+

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.04.043

关键词

Vaccine hesitancy; WHO; SAGE; Recommendations; Vaccine acceptance; Vaccine refusal

资金

  1. Novartis
  2. GSK

向作者/读者索取更多资源

Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and the performance of national immunization programmes, the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on Vaccine Hesitancy [1], carried out a review, and proposed a set of recommendations directed to the public health community, to WHO and its partners, and to the World Health Organization (WHO) member states. The final recommendations issued by SAGE in October 2014 fall into three categories: (I) those focused on the need to increase the understanding of vaccine hesitancy, its determinants and the rapidly changing challenges it entails; (2) those focused on dealing with the structures and organizational capacity to decrease hesitancy and increase acceptance of vaccines at the global, national and local levels; (3) and those focused on the sharing of lessons learnt and effective practices from various countries and settings as well as the development, validation and implementation of new tools to address hesitancy. (C) 2015 Published by Elsevier Ltd. This is an open access article under the CC BY license.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据